Edition:
United States

Genetic Technologies Ltd (GTG.AX)

GTG.AX on Australia Stock Exchange

0.01AUD
26 May 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.01
Open
$0.01
Day's High
$0.01
Day's Low
$0.01
Volume
250,000
Avg. Vol
1,324,044
52-wk High
$0.02
52-wk Low
$0.01

GTG.AX

Chart for GTG.AX

About

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment... (more)
No analyst recommendations are available for GTG.AX.

Overall

Beta: 2.13
Market Cap(Mil.): $21.92
Shares Outstanding(Mil.): 2,435.28
Dividend: --
Yield (%): --

Financials

  GTG.AX Industry Sector
P/E (TTM): -- 141.29 17.43
EPS (TTM): -0.00 -- --
ROI: -53.09 2.17 -5.41
ROE: -53.35 0.10 -4.69

BRIEF-Genetic Technologies and the University of Melbourne enter into worldwide license agreement to develop colorectal cancer risk assessment test

* Genetic Technologies Limited and the University of Melbourne enter into exclusive worldwide license agreement to develop colorectal cancer risk assessment test Source text for Eikon: Further company coverage:

Nov 29 2016

BRIEF-Genetic Technologies entered into license agreement with University Of Melbourne

* Asx alert-license agreement to develop colorectal cancer risk test-GTG.AX

Nov 28 2016

More From Around the Web

Earnings vs. Estimates